Finally, the Prostate Cancer Antigen 3 (PCA3), a lncRNA of 3 Kb in length transcribed in chromosome 9, is present in prostate cancer with high tissue-expression specificity, described first by Bussemakers et al. in 1999 [49]. This evidence concerns the gene PCA3 and prostate carcinoma.